TRANS-3-(4-(TRIFLUOROMETHYL)PHENYL)CYCLOBUTANOL, 95.0%, 100mg

5(6)-Carboxyfluorescein, = 97% (HPLC), 5g

1-(4-Bromophenyl)ethane-1,2-diol, 95.0%, 100mg

(2-Oxo-benzooxazol-3-yl)-acetic acid, 95.0%, 1g

2'-Deoxyguanosine>99.0%(HPLC)1g

[1-(6-Ethoxy-2-methylsulfanyl-pyrimidin-4-yl)-piperidin-4-ylmethyl]-carbamic acid tert-butyl ester, 95.0%, 250mg

TERT-BUTYL 6-AMINO-3-AZABICYCLO[4.1.0]HEPTANE-3-CARBOXYLATE, 95.0%, 100mg

methyl 5-{[(2S)-2-{[(tert-butoxy)carbonyl]amino}-3-(4-carbamoyl-2,6-dimethylphenyl)-N-[(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]propanamido]methyl}-2-methoxybenzoate, 98%, 50mg

Methyl 2-bromo-5-methoxybenzoate, 95.0%, 500g

Acetosiringona, mínimo 98 %, 500 mg, envase de vidrio

Benzylboronic acid pinacol ester, 97.00%, 1g

Benzenemethanol, 3-bromo-4-(trifluoromethyl), 95.0%, 100mg

2-(3-(Difluoromethyl)-5-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 250mg